Effect of removal of AuraOnce™ laryngeal mask in awake or deep anaesthesia: a randomized controlled trial

Background: The manufacturer Ambu® recommends that the AuraOnce™ laryngeal mask be removed once the patient is fully awake. Studies have shown benefit in removal of the laryngeal mask airway while a patient is deeply anaesthetized. Current evidence is inconclusive, as to which approach is preferable and safer in adults. Methods: one hundred and sixteen adult patients were randomly assigned to two groups of 58. For the deep arm; The AuraOnceTM laryngeal mask was removed after attaining an end tidal minimum alveolar concentration of Isoflurane of 1.15%. Occurrence of airway complication(s) (One or more of the following; Airway obstruction requiring airway manipulation; Laryngospasm; Desaturation to 90% or less on pulse oximetry) was noted until the subject was fully awake (appropriate response to command) in the post-anaesthesia care unit. For the awake arm; The AuraOnceTM laryngeal mask was removed on attaining an end tidal minimum alveolar concentration of Isoflurane of \u3c0.5% and an appropriate response to command or obtaining appropriate response to command irrespective of end tidal concentration. Occurrence of airway complication(s) in theatre and post anaesthesia care unit was recorded. Time to theatre exit was recorded for both groups. Results: Baseline demographic characteristics were similar between the groups. More airway complications were encountered in the Deep arm - 13 (22.4%) relative to the Awake arm -5 (8.6%), this was found to be statistically and clinically significant, P value P=0.040, odds ratio 3.0622; 95% CI, 1.0139 to 9.2483. Conclusion: The removal of the AuraOnceTM laryngeal mask while the patient is still deeply anaesthetised is not as safe as or safer than awake removal

Effect of removal of AuraOnceTM laryngeal mask in awake or deep anaesthesia: a randomized controlled trial

Background: The manufacturer Ambu\uae recommends that the AuraOnce\u2122 laryngeal mask be removed once the patient is fully awake. Studies have shown benefit in removal of the laryngeal mask airway while a patient is deeply anaesthetized. Current evidence is inconclusive, as to which approach is preferable and safer in adults. Methods: one hundred and sixteen adult patients were randomly assigned to two groups of 58. For the deep arm; The AuraOnceTM laryngeal mask was removed after attaining an end tidal minimum alveolar concentration of Isoflurane of 1.15%. Occurrence of airway complication(s) (One or more of the following; Airway obstruction requiring airway manipulation; Laryngospasm; Desaturation to 90% or less on pulse oximetry) was noted until the subject was fully awake (appropriate response to command) in the post-anaesthesia care unit. For the awake arm; The AuraOnceTM laryngeal mask was removed on attaining an end tidal minimum alveolar concentration of Isoflurane of <0.5% and an appropriate response to command or obtaining appropriate response to command irrespective of end tidal concentration. Occurrence of airway complication(s) in theatre and post anaesthesia care unit was recorded. Time to theatre exit was recorded for both groups. Results: Baseline demographic characteristics were similar between the groups. More airway complications were encountered in the Deep arm - 13 (22.4%) relative to the Awake arm -5 (8.6%), this was found to be statistically and clinically significant, P value P=0.040, odds ratio 3.0622; 95% CI, 1.0139 to 9.2483. Conclusion: The removal of the AuraOnceTM laryngeal mask while the patient is still deeply anaesthetised is not as safe as or safer than awake removal

Impact of Deep Versus Awake Laryngeal Mask Airway Removal on Airway Complications in Spontaneously Breathing Adult Patients following Isoflurane General Anesthesia.

Background: The Laryngeal Mask Airway (LMA) is one of several supra-glottic airway management devices used in anaesthesia. The scope of use of the LMA is progressively expanding to areas previously contraindicated, for instance laparoscopy and prone position surgery. Certain aspects of LMA use remain unsettled. Whether to remove the LMA when a patient is “awake” vs “deep” following anaesthesia is one such area. The manufacturer Ambu® recommends that the AuraOnce™ LMA be removed once the patient is fully awake and protective airway reflexes are active. Despite this, several studies have shown benefit in removal of the LMA while a patient is “deep” (anaesthetized). Current evidence is inconclusive as to which approach is preferable and safer in adults. Primary Objective: To compare the impact of having LMA removal deep versus awake on the occurrence of airway complications following general anaesthesia in spontaneously breathing adult patients using Isoflurane as the sole volatile agent. Secondary Objective: To compare the impact of deep versus awake LMA removal on anaesthesia theatre turn-around time. Primary outcome measure(s): Airway complication(s), defined as; one or more of the following; Airway obstruction requiring airway manipulation; Laryngospasm; Desaturation to 90% or less on pulse oximetry. Secondary outcome measure(s): Time to theatre exit Study Setting: The Aga Khan University Hospital, Nairobi, Kenya. Study Design: A prospective randomized control trial (open). Sample size: A sample size of 116 participants, 58 in each arm. Study population: ASA I and II patients aged 18-65 years scheduled for theatre for low to moderate risk, non-emergent surgery. Procedure: 116 adult patients were randomly assigned to one of two groups. A standard anaesthesia protocol was used for induction and maintenance of anaesthesia. For the deep arm; The LMA was removed at the end of surgery after attaining an end tidal minimum alveolar concentration of Isoflurane of 1.15%. Occurrence of airway complication(s) (One or more of the following; Airway obstruction requiring airway manipulation; Laryngospasm; Desaturation to 90% or less on pulse oximetry) was noted until the subject was fully awake (appropriate response to command) in the post anaesthesia care unit. For the awake arm; The LMA was removed on attaining an end tidal minimum alveolar concentration of Isoflurane of \u3c0.5% and an appropriate response to command or obtaining appropriate response to command irrespective of end tidal concentration. Occurrence of airway complication(s) (One or more of the following; Airway obstruction requiring airway manipulation; Laryngospasm; Desaturation to 90% or less on pulse oximetry) was in theatre and post anaesthesia care unit. Time to theatre exit was recorded for both groups from the point of attaining an end tidal minimum alveolar concentration of Isoflurane of 1.15% to the point of theatre exit, in both groups. These processes were in addition to standard care. Data collection: Parameters of interest being; Airway obstruction requiring airway manipulation, laryngospasm, desaturation to 90% or less on pulse oximetry, all of which were composited to define ‘airway complication’. Time to theatre exit after attaining an end tidal of 1.15% Isoflurane. Results: 116 ASA I & II patients scheduled to undergo elective surgery were included in this study, 58 (50%) subjects in the awake arm and 58 (50%) subjects in the deep arm. Baseline demographic characteristics were similar between the groups. More airway complications were encountered in the Deep arm - 13 (22.4%) relative to the Awake arm -5 (8.6%), this was found to be statistically and clinically significant, P value P=0.040, odds ratio 3.0622; 95% CI, 1.0139 to 9.2483. Conclusion: The study concludes that there is a significant difference in the occurrence of airway complications when the laryngeal mask airway is removed deep (anaesthetized) compared to awake (appropriate response to command). In this regard, the removal of the LMA while the patient is still deeply anaesthetised is not as safe as or safer than awake laryngeal mask airway removal